PTHS 8-K 2026-10-30

Pelthos Therapeutics Inc. (PTHS) 8-K dated 2026-10-30 — accession 0001104659-26-120457.

Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.

Pelthos Therapeutics Inc. filed a 8-K on 2026-10-30. Accession 0001104659-26-120457.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03), Unregistered share sale (Item 3.02), Change to holders' rights (Item 3.03), Director/officer change (Item 5.02), Bylaws or fiscal year change (Item 5.03). SEC EDGAR holds the official filing and its exhibits.

Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.

Not investment advice. The PTHS SEC hub lists recent forms. The stock page is the research view.